Log In
Print this Print this

NHS-IL12 (M9241)

  Manage Alerts
Collapse Summary General Information
Company Merck KGaA
DescriptionImmunocytokine composed of 2 IL-12 heterodimers, each fused to one of the H-chains of the NHS76 antibody
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today